BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blum K, Kazmi S, Modestino EJ, Downs BW, Bagchi D, Baron D, McLaughlin T, Green R, Jalali R, Thanos PK, Elman I, Badgaiyan RD, Bowirrat A, Gold MS. A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration. J Pers Med 2021;11:212. [PMID: 33809702 DOI: 10.3390/jpm11030212] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Madigan MA, Gupta A, Bowirrat A, Baron D, Badgaiyan RD, Elman I, Dennen CA, Braverman ER, Gold MS, Blum K. Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence? Int J Environ Res Public Health 2022;19:6395. [PMID: 35681980 DOI: 10.3390/ijerph19116395] [Reference Citation Analysis]
2 White O, Roeder N, Blum K, Eiden RD, Thanos PK. Prenatal Effects of Nicotine on Obesity Risks: A Narrative Review. IJERPH 2022;19:9477. [DOI: 10.3390/ijerph19159477] [Reference Citation Analysis]
3 Gupta A, Bowirrat A, Gomez LL, Baron D, Elman I, Giordano J, Jalali R, Badgaiyan RD, Modestino EJ, Gold MS, Braverman ER, Bajaj A, Blum K. Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors. Int J Environ Res Public Health 2022;19:552. [PMID: 35010811 DOI: 10.3390/ijerph19010552] [Reference Citation Analysis]
4 Blum K, Bowirrat A, Braverman ER, Baron D, Cadet JL, Kazmi S, Elman I, Thanos PK, Badgaiyan RD, Downs WB, Bagchi D, Llanos-Gomez L, Gold MS. Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions. Int J Environ Res Public Health 2021;18:11529. [PMID: 34770047 DOI: 10.3390/ijerph182111529] [Reference Citation Analysis]
5 Lee SJ. Advances in Personalized Medicines along with Functional Genomics and Pharmacogenomics. J Pers Med 2021;11:941. [PMID: 34683082 DOI: 10.3390/jpm11100941] [Reference Citation Analysis]